Dr. Evans is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
384 Airport Rd
Hazle Township, PA 18202Phone+1 570-501-1242Fax+1 570-501-1252
Education & Training
University of MarylandFellowship, Hematology and Medical Oncology, 2008 - 2011
University of ConnecticutResidency, Internal Medicine, 2005 - 2008
St. George's University School of MedicineClass of 2005
Certifications & Licensure
PA State Medical License 2010 - 2024
MD State Medical License 2010 - 2010- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Rituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia Start of enrollment: 2013 Dec 09
- Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Start of enrollment: 2014 Feb 20
Publications & Presentations
PubMed
- 6 citationsRisk assessment in human immunodeficiency virus-associated acute myeloid leukemia.Michael W. Evans, Anthony D. Sung, Ivana Gojo, Michael L. Tidwell, Jacqueline Greer
Leukemia & Lymphoma. 2012-04-27 - 6 citationsRituximab treatment for thrombotic thrombocytopenic purpura associated with human immunodeficiency virus failing extensive treatment with plasma exchange: a report of ...Michael W. Evans, Leroy B. Vaughan, Victoria S. Giffi, Ann B. Zimrin, John R. Hess
AIDS Patient Care and Stds. 2010-06-21
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
